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In addition to the major ectodomain, the gp41 transmembrane glycoprotein of HIV-1 is now known to have a minor ectodomain that is
part of the long C-terminal tail. Both ectodomains are highly antigenic, carry neutralizing and non-neutralizing epitopes, and are involved in
virus-mediated fusion activity. However, data have so far been biologically based, and derived solely from T cell line-adapted (TCLA), B
clade viruses. Here we have carried out sequence and theoretically based structural analyses of 357 gp41 C-terminal sequences of mainly
primary isolates of HIV-1 clades A, B, C, and D. Data show that all these viruses have the potential to form a tail loop structure (the minor
ectodomain) supported by three, h-sheet, membrane-spanning domains (MSDs). This means that the first (N-terminal) tyrosine-based sorting
signal of the gp41 tail is situated outside the cell membrane and is non-functional, and that gp41 that reaches the cell surface may be recycled
back into the cytoplasm through the activity of the second tyrosine-sorting signal. However, we suggest that only a minority of cell-associated
gp41 molecules – those destined for incorporation into virions – has 3 MSDs and the minor ectodomain. Most intracellular gp41 has the
conventional single MSD, no minor ectodomain, a functional first tyrosine-based sorting signal, and in line with current thinking is degraded
intracellularly. The gp41 structural diversity suggested here can be viewed as an evolutionary strategy to minimize HIV-1 envelope
glycoprotein expression on the cell surface, and hence possible cytotoxicity and immune attack on the infected cell.
D 2005 Elsevier Inc. All rights reserved.Keywords: HIV-1; Envelope protein; gp41 envelope protein; gp41 C-terminal tail; Structure; Conformation; Membrane spanning domain; Tyrosine-sorting
signalIntroduction
Viruses of the Lentivirus genus of the Retroviridae have
a single virus-encoded, envelope glycoprotein (Env). This is
a type I membrane protein with the N-terminus on the
outside of the cell. Env mRNA is synthesized in the nucleus,
and exported with the help of the viral Rev protein to the
cytoplasm where it is translated as a gp160 precursor.
Gp160 is then translocated through the rough endoplasmic
reticulum (ER) (Dettenhofer and Yu, 2001), and folded with0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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University School of Medicine, Atlanta, GA 30322, USA.the assistance of the chaperone proteins, calreticulin, and
calnexin (Otteken et al., 1996). Glycans are added in the
Golgi, and subsequently trimmed (Dash et al., 1994;
Fenouillet and Jones, 1995). Gp160 oligomerizes in the
ER, forming a non-covalently linked trimer (Earl et al.,
1991; Willey et al., 1988). Most gp160 is degraded, but
about 5–15% is cleaved into gp120 (distal) and gp41
(membrane anchor) components. These remain associated
non-covalently and are targeted to the cell surface (see
below). Gp120-gp41 trimers are incorporated into progeny
virions. Gp120 can be shed from the surface of cells and
virions (Willey et al., 1988, 1991).
Enzymatic cleavage of gp160 to gp120-gp41 is essential
for Env function. Uncleaved gp160 cannot induce syncy-
tium formation, and virions with uncleaved gp160 are not05) 284 – 296
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probably because so little reaches the cell surface (Duensing
et al., 1995; Pal et al., 1991; Pfeiffer et al., 1997; Willey et
al., 1988). HIV-1 gp160 is cleaved between residues 518R
and 519A by the subtilisin/kexin-like Ca2+-dependent con-
vertases such as furin, PACE4, PC5/6-B, and PC1 (Mor-
ikawa et al., 1993; Moulard et al., 1994; Vollenweider et al.,
1996). Gp160 is probably cleaved by more than one cellular
protease.
Gp160 cleavage occurs in the trans-Golgi network
(TGN) or after it exits the TGN (Bultmann et al., 2000;
Pal et al., 1991; Pfeiffer et al., 1997; Stein and Engelman,
1990). Brefeldin A, A1Fn, monensin, and tunicamycin
inhibit gp160 cleavage even when gp160 is allowed to
accumulate in the TGN, suggesting that cleavage occurs in
the late compartment of the Golgi or after gp160 has exited
from the Golgi (Dewar et al., 1989; Kantanen et al., 1995;
Pal et al., 1991, 1988). Cleavage may occur in an acidic
compartment, as it was inhibited by NH4Cl and partially
inhibited by chloroquine (Courageot et al., 1999; Willey et
al., 1988). However, these inhibitors may prevent gp160
from reaching the correct intracellular site for cleavage.
Methionine methyl ester failed to inhibit gp160 cleavage,
indicating that cleavage may occur in a non-lysosomal
compartment (Willey et al., 1988). Only a small proportion
of gp160 (5–40%) is cleaved into gp120-gp41, and this
depends on the host cell (Bird et al., 1990; Hallenberger et
al., 1993; Jose et al., 1997; Kimura et al., 1996; Kozarsky et
al., 1989; Moulard et al., 1999; Pfeiffer et al., 1997; Willey
et al., 1988, 1991). For example, 10–20% of gp160 is
cleaved in peripheral blood lymphocytes (Willey et al.,
1988).
Uncleaved, trimeric gp160 is degraded in the ER and
lysosomes. However, the proportion degraded in each
location is not known. According to Willey et al., most
gp160 leaves the ER and reaches the Golgi, and the minority
that remains in the ER is degraded there (Willey et al.,
1988). However, others find that most gp160 remains in the
ER and is degraded (Bultmann et al., 2000; Courageot et al.,
1999; Hallenberger et al., 1993; Jabbar and Nayak, 1990;
Pfeiffer et al., 1997), or is rapidly sent to lysosomes and
degraded (Jabbar and Nayak, 1990; Pfeiffer et al., 1997).
Whichever the location, degradation is relatively rapid, and
only 10–20% of gp160 remains after 8 h (Willey et al.,
1988). When prevented from leaving the ER, gp160
accumulates there and is degraded (Courageot et al., 1999;
Pal et al., 1991; Willey et al., 1991). Gp160 degradation has
also been observed in proteosomes (Bultmann et al., 2000).
The consensus view is that most gp160 is degraded in the
ER, and only a minority reaches the Golgi. Of the latter,
most (85–95%) is degraded in lysosomes, and the
remainder is targeted as gp120-gp41 to the cell surface
(Willey et al., 1988). Gp120 is relatively stable, and 30–50%
can be detected as secreted or intracellular protein 24 h
later (Bird et al., 1990; Willey et al., 1988, 1991). The
amount of gp160 secreted from the cell is less than 10% ofthe gp120 secreted (Willey et al., 1988), although the amount
varies with the type of host cell (Moulard et al., 1999).
Tyrosine-dependent sorting signals (YxxB, where x repre-
sents any amino acid residue and B represents a bulky
hydrophobic residue), and possibly di-leucine-sorting sig-
nals are found in the C-terminal tail of gp41, and have been
implicated in transport of gp160 and gp120-gp41 (see
Results and discussion section and Berlioz-Torrent et al.,
1999; Boge et al., 1998; Bu et al., 2004; Deschambeault et
al., 1999; Egan et al., 1996; Lodge et al., 1997; Ohno et al.,
1997; Owens et al., 1991; Rowell et al., 1995; West et al.,
2002; Wyss et al., 2001).
Gp120 is the distal part of the envelope glycoprotein
trimer, and recognizes the primary CD4 receptor, and
coreceptors on the target cell. Gp41 anchors the envelope
glycoprotein in the cell or virion membrane, and mediates
the virion fusion entry process that is activated by receptor
binding. The N-terminal peptide of gp41 is inserted into the
membrane of the target cell and leads to fusion of the virion
and cell membranes, entry of the virus genome and
associated proteins into the cell, and infection. Gp41
comprises an ectodomain, a single membrane-spanning
domain (MSD), and a long C-terminal tail that in the past
has been viewed as being entirely contained inside the cell
or virion (Gallaher, 1987; Gallaher et al., 1989; Gonzalez-
Scarano et al., 1987; Levy, 1998; White, 1990). However,
there is abundant evidence that HIV-1 virions can be
neutralized by antibodies directed to an epitope in the C-
terminal tail (Buratti et al., 1998; Chanh et al., 1986;
Cleveland et al., 2000a,b, 2003; Dalgleish et al., 1988;
Durrani et al., 1998; Ho et al., 1987; McInerney et al., 1999;
McLain et al., 1995, 1996, 2001; Newton et al., 1995;
Reading et al., 2003). Since antibodies do not cross lipid
bilayers, this means that part of the tail is exposed on the
virion surface. We have called this exposed region of the
gp41 tail the minor ectodomain, to distinguish it from the
better known, and larger, major ectodomain. Non-neutrali-
zing antibodies specific for the minor ectodomain have also
been shown to bind virions (Cleveland et al., 2003; McLain
et al., 2001), providing further evidence of the external-
ization of the minor ectodomain. Binding of antibody is
abrogated by pre-treatment of virions with protease, again
supporting the external location of this part of the tail
(Cleveland et al., 2003). More recently, we demonstrated for
the first time that neutralizing and non-neutralizing anti-
bodies to the minor ectodomain bind to infected cells and
that the neutralizing antibodies inhibit fusion of infected and
non-infected cells (Cheung et al., 2005; Heap et al., 2005).
Thus, part of the gp41 C-terminal tail is exposed on the
surface of both infected cells and virions.
Until now, evidence for the exposure of part of the gp41
C-terminal tail has been based on the study of HIV-1 B
clade, T cell line-adapted (TCLA) viruses, and the generality
of the existence of the minor ectodomain, and its structural
basis, have not been explored. To remedy this, we have here
analyzed 357 gp41 C-terminal tail database sequences from
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could potentially have a minor ectodomain of approximately
40 residues, supported by three MSDs, and an internal tail of
approximately 100 residues. We shall further suggest that
this 3-MSD form of gp41 coexists with the accepted 1-MSD
form of gp41, and that the 3-MSD form represents a minor
population of intracellular gp41 that is destined for
incorporation into virions. In contrast, 1-MSD gp41 is the
majority form of intracellular gp41, most of which is
degraded.Results and discussion
Sequence comparisons
Regions of conservation in the gp41 sequence 690–
793 of HIV-1 clades A to D are summarized in Fig. 1,
with residues numbered according to Ratner et al. (1985).
The only very highly conserved region throughout all
clades is 713NRVRQGYSPLSFQ725, which contains the
most N-terminal (first) tyrosine-dependent sorting signal
(719YSPL722). As expected, the region comprising the ac-
cepted MSD, 690KIFIMIVGGLIGLRIVFAVLSIV712, is
highly conserved and forms part of a larger highly conserved
sequence 690KIFIMIVGGLIGLRIVFAVLSIVNRVRQ-
GYSPLSFQ725, which includes the region surrounding the
first tyrosine-dependent sorting signal. However, there areFig. 1. Summary of the conservation of gp41 C-terminal amino acid residuesconservative substitutions in individual clade consensus
sequences of 700I-V (clade B), 705V-I (clade C), 711I-L (clade
D), and 712V-I (clade A). The region 767RSLCLFSYHRLR779
containing the second potential tyrosine-dependent sorting
signal (775YHRL778) is highly conserved. The highly con-
served 790ELLG793 contains a potential di-leucine signal, but
the only di-leucine signal known to be functional in gp41 is
862LL863 (Wyss et al., 2001).
The Kennedy sequence (731PRGPDRPGRIEEEG-
GEQDRDRS752) in clade B viruses contains the neutralizing
epitope core sequence 746ERDRD750, and two non-neutraliz-
ing epitopes (734PDRPEG739 and 740IEEE743) (Chanh et al.,
1986; Dalgleish et al., 1988; Evans et al., 1989; Ho et al.,
1987; Kennedy et al., 1986; Niedrig et al., 1992; Vella et al.,
1993). Overall the Kennedy sequence is only poorly to
moderately conserved. Specifically 731PRGPDRPGRI740 and
747QDRDRS752 are poorly to moderately conserved, but
741EEEGGE746 is moderately to highly conserved.
741EEEGGE746 is notable in having 67% acidic residues.
746ERDRD750 is present only in clade B and the recombinant
CRF03_AB clade. Clades A and C have 746EQDRD750 and
clade D has 746EQGRG750. The exchange of 747R (basic,
ionizable, hydrophilic, with a long side chain) for Q (polar,
hydrophilic, amidic, with a shorter side chain) might create a
different epitope, and 746ERDRD750-specific neutralizing
antibody may not recognize 746EQDRD750.
The gp41 tail reading frame overlaps the second exons of
tat (+1 relative to env) and rev (+2). Both of the latter start690–793 of HIV-1 clades A to D, using a 7-residue moving window.
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of Env. Tat and Rev stop at the equivalent of the codons for
residues 740 and 816 of Env, respectively. This is the only
part of the env sequence where all three ORFs are used, yet
counter-intuitively, conservation of 725–740 of Env ranges
from poor to high. It may be that the tat and/or rev
sequences are conserved at the expense of env. All clades
have a very highly conserved 745G (100%), 758G (99.9%),
and 764W (99.4%). The conservation of 745G and 758G may
be a consequence of the reading frame shared with Rev. The
last two bases of a rev codon are the first two bases of the
env codon. Thus, if rev requires a tryptophan in its second
exon, the overlapping codon of env has to be glycine, since
tryptophan is only encoded by UGG, while the codon for
glycine is GGx. The reason why 764W is very highly
conserved is not clear, but any change in its codon results in
a different amino acid residue or a stop codon (UGA or
UAG). Regions of conservation for clades A to D consensus
sequences of gp41 residues 690–793, and an overall
consensus sequence are summarized in Fig. 2.
Structure predications
The consensus sequences of HIV-1 clades A to D
derived above were analyzed individually (see Materials
and methods), but as the predicted structures were virtuallyFig. 2. Consensus sequences for gp41 C-terminal amino acid residues 690–793 of
The potential tyrosine-dependent sorting signals are in red. A potential di-leucine
while residues that vary are in green. Where two residues are equally represented
sequence is based on the larger number of sequences analyzed. The proposed first,
Kennedy sequence.identical, only clade A data are presented. According to
Kyte and Doolittle (1982), four regions (690–699, 702–
711, 758–763, and 783–787) have hydropathy values of
>1.6, indicating that they are potential MSDs (Fig. 3a).
There are two single point peaks of 1.6 at residues 771
and 781, but the values of surrounding residues are too
low for these to form an MSD. The Kennedy region
(731–752) is highly hydrophilic, with values of mainly
1, suggesting that it is exposed to solvent. Essentially the
same conclusions were reached (data not shown) using
other hydropathy prediction algorithms (Eisenberg et al.,
1984; Hopp and Woods, 1981; Sweet and Eisenberg,
1983).
Five regions (690–694, 704–711, 740–747, 758–766,
and 779–793) have a-helix potentials of >1.03 (Fig. 3b),
and four regions (690–719, 753–761, 770–777, and 779–
788) have h-sheet values of >1.05 (Fig. 3c). The most likely
conformation is that with the highest predicted value (Chou
and Fasman, 1978). Thus, 690–719 (1.34) is likely to be h-
sheet. In this region there is a dip to 1.05 at residue 702,
suggesting that 690–719 may comprise two discrete regions
(690–701 and 703–719). This is consistent with the two
hydropathic regions predicted above. There are two regions
with different conformations adjacent to each other at 753–
766, with 753–761 showing higher h-sheet potential and
761–766 showing greater a-helix potential. 779–788 couldHIV-1 clades A to D combined (top line), and for clades A to D individually.
signal is pink. Residues common to the majority of sequences are in black,
between the consensus sequences of the four clades, the overall consensus
second, and third MSDs are overlined. Underlined is the antigenically active
Fig. 3. Analysis of the structure of the gp41 C-terminal residues 690–793 of HIV-1 clade A using various algorithms: (a) hydropathy prediction, where high
values represent the more hydrophobic regions; (b) a-helix prediction, where high values indicate a greater probability of a-helical structure; (c) h-sheet
prediction, where high values indicate a greater probability of h-sheet structure; (d) h-turn prediction, where high values indicate a greater probability of a h-
turn; (e) polarity prediction, where high values suggest high polarity; and (f) buried residue prediction, where high values suggest buried residues.
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shows no potential for h-sheet formation with values <0.95.
However, 740–747 of the Kennedy region that in clade B
TCLA viruses contains the highly immunogenic and anti-genic epitope 740IEEE743 (Cleveland et al., 2000a) may form
an a-helix (>1.03).
There are potential h-turns at 702, 721, 731, 733, 748,
768, and 778 (Fig. 3d). The h-turn at 702 is consistent with
Fig. 4. Schematic showing the suggested membrane insertion of a monomer
of (a) the 1-MSD and (b) the 3-MSD forms of gp41 of HIV-1 clades A to D.
The positions of the two potential tyrosine-sorting signals and the minor
ectodomain containing the Kennedy sequence are shown. The major
ectodomain at the N-terminus of gp41 and gp120 have been omitted. The
distance shown in (b) between MSD 2 and 3 (reading from left to right) is
conjectural.
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discrete MSDs. Residue 721P is present in most of the first
tyrosine-dependent sorting signals (719YSPL722) and is
discussed later. The Kennedy region contains potential h-
turns at 731, 733, and 748, and with the prediction of only
one short region of a-helix and no h-sheet, the region is
probably unstructured. The potential h-turn at 749R might be
important for maintaining the complex conformational
neutralizing epitope 746ERDRD750 found in clade B virions
(Buratti et al., 1998; Cheung et al., 2005; Cleveland et al.,
2000a,b, 2003; Heap et al., 2005; McLain et al., 2001;
Reading et al., 2003; Vella et al., 1993). h-turns at 768 and
778 would occur after the putative third MSD (see below).
There are four highly non-polar regions (694–699, 708–
711, 720–725, and 759–762) (Fig. 3e). Regions 694–699
and 708–711 coincide with the MSD 1 and 2 predicted
above. The unequal polarity of these two domains adds to
the suggestion that they are separate entities. Residues 720–
725 contain the first tyrosine-dependent sorting signal, but
the significance of its lack of polarity is not clear. Residues
759–762 coincide with the possible location of the third
MSD predicted above (754–763). Region 780–793 is
moderately polar and unlikely to form an MSD. The
Kennedy region is the most polar region in the analyzed
sequence, consistent with it being exposed to aqueous
solvent and with its antigenic properties.
Regions 694–712 (containing the predicted MSD 1 and
2 at 691–700 and 703–712) and 755–763 are likely to be
inaccessible to aqueous solvent (Fig. 3f). The dip at the
center of 694–712 (residue 703) supports the prediction that
this region comprises two MSDs. Region 755–763 coin-
cides with the predicted third MSD (754–763). The
Kennedy region is accessible to solvent.
Taken together, these data suggest that the gp41 of HIV-1
clades A, B, C, and D all have the potential to have three
MSDs in a h-sheet conformation. MSD 1 and 2 are
connected by a short h-turn (701GL702), and MSD 2 and 3
support the highly antigenic Kennedy sequence on the
outside of the cell or virion. Further the MSDs all have
significant parallel and anti-parallel h-strand potential
(Lifson and Sander, 1979; data not shown). The 1- and 3-
MSD forms of gp41 are shown schematically in Figs. 4a and
b. The significance of the new positioning of the potential
tyrosine-sorting signals is discussed below. While MSDs are
typically a-helical and approximately 20 residues in length
(Sabatini et al., 1982; Singer, 1990), h-sheets as short as 7
residues form MSDs as part of transmembrane h-barrel
proteins of bacteria, choroplasts, and mitochondria (Schultz,
2003). Short h-turns connect sequential MSDs and do not
normally occur within MSDs (Jahnig, 1990), but the h-turn
may intrude into the membrane, as suggested for herpes
simplex virus glycoprotein B (Pellett et al., 1985). An
arginine residue is unlikely to occur in the middle of an
MSD (Singer, 1990), and R703 of the 3-MSD form of gp41
is predicted to be on the membrane surface, where the polar
head groups of membrane lipids can neutralize its positivecharge. However, we shall suggest below that the 3-MSD
gp41 is a minority form that is selectively incorporated into
the plasma membrane and virions, and that most intra-
cellular gp41 exists in the 1-MSD conformation. Finally
preliminary sequence and structural analysis suggests that
other primate lentiviruses (HIV-2, SIV) have the potential to
form a 3-MSD structure (unpublished data).
Conclusions
Gp41 molecules of HIV-1 clades A to D all have the
potential to form three short MSDs, which most likely have a
h-sheet conformation. The position of the third MSD places
the first potential tyrosine-dependent sorting signal outside
the membrane, where it is non-functional. All viruses have a
hydrophilic, unstructured region of 41 residues supported by
MSDs 2 and 3 that probably equates to the antigenically and
biologically active minor ectodomain of HIV-1 clade B,
TCLA viruses. The definition and values of the peaks
obtained in the above analysis make the data highly
significant. The position and number of residues in the
MSDs and other regions of interest are summarized in Table 1
and Fig. 5. The latter also shows possible interactions of
elements of the proposed new 3-MSD conformation.
Possible implications of the existence of multiple MSDs on
the functioning of tyrosine-dependent sorting signals in the
C-terminal tail of gp41
The HIV-1 gp41 tail has an (N-terminal or first) tyrosine
signal (719YSPL722) that functions in endocytosis (Berlioz-
Torrent et al., 1999; Boge et al., 1998; Deschambeault et al.,
Table 1
Predicted location of residues in the 3-MSD conformation of the gp41 of
HIV-1 clades A to D in the virion or cell membrane
Position Number of residues
Major ectodomain 512–690 179
MSD 1 691–700 10
Turn 701–702 2
MSD 2 703–712 10
Minor ectodomain (external loop) 713–753 41
MSD 3 754–763 10
Internala 764–863 100
a Comprises 30 residues analyzed here, and 70 not analyzed.
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1995; West et al., 2002) and basolateral sorting (Descham-
beault et al., 1999; Lodge et al., 1997; Owens et al., 1991).Fig. 5. Representation of some possible interactions of the minor ectodomain (resi
trimer. Shown are residues 645–863, comprising part of the main ectodomain, the
HIV-1 NL-4.3 (clade B). Only a monomer is represented. There may be interactio
major ectodomain, between the minor ectodomain and elements of gp120, or with
the trimer could also interact with each other. The antigenically active Kennedy se
shown as the outer face of the minor ectodomain.The signal sequence and upstream residues are highly to
very highly conserved in clades A to D: 716R = 100%, 717Q =
96.4%, 718G = 99.95%, 719Y = 99.7%, 720S = 99.5%, 721P =
99.8%, 722L = 96.9%. The glycine immediately before a
tyrosine signal signifies that it can function in the TGN to
target the protein to lysosomes. Also for signal functionality
there is a strict requirement that the tyrosine residue is the
7th–11th residue from the membrane (Rohrer et al., 1996).
Gp41 is also involved in basolateral localization of envelope
protein in the plasma membrane of polarized cells (Owens et
al., 1991), a property that is lost when the tyrosine of the first
signal is substituted (Deschambeault et al., 1999; Lodge et
al., 1997). In the 1-MSD model of gp41, Gallaher et al.
(1989) have proposed that the MSD ends at residue 712V, and
thus 719Y will be the 7th residue from the membrane, anddues 713–753) of the 3-MSD form of gp41 with other elements of the Env
MSDs, the minor ectodomain, and the entire C-terminal tail of the gp41 of
ns between MSD 1, 2, and 3, between the minor ectodomain and the gp41
the other gp41 monomers that form the trimer (arrows). The nine MSDs of
quence (731–752) containing neutralizing and non-neutralizing epitopes is
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depends on knowing precisely which residue ends the MSD.
Often a charged residue that acts as a stopper defines the
end, and it is possible that the gp41 MSD could end at 714R.
If so, 719Y would be 5 residues from the membrane, and this
might compromise the endocytosis, basolateral sorting, and
lysosomal targeting functions of the signal. The minimum
distance of the tyrosine-signal from the membrane is
required for both direct lysosomal targeting and endocytosis
(Collawn et al., 1990; Pytowski et al., 1995; Trowbridge
and Collawn, 1992; Trowbridge et al., 1993). However,
only lysosomal targeting signals have a strict maximum
distance from the membrane (Collawn, 1990; Rohrer et al.,
1996; Trowbridge and Collawn, 1992; Trowbridge et al.,
1993). The fact that the first tyrosine signal functions in
endocytosis (as referenced above) argues that it is indeed at
the required distance from the membrane, but at the time of
writing there are no experimental data to show if the signal
is active in directing gp41 to lysosomes. The 3-MSD model,
as stated above, puts the first tyrosine signal outside the
membrane where it is non-functional for any transport
function (Fig. 5).
Adaptor protein (AP) complexes interact with tyrosine-
sorting signals. AP-1 and AP-3 complexes are mainly found
in the TGN and function in lysosomal targeting, while AP-2 is
predominantly localized to the plasma membrane and
functions in endocytosis. They have distinct preferences for
specific residues or combinations of residues of the tyrosine
signals, although there is overlap, particularly with AP-1 and
AP-3 complexes (Table 2) (Boll et al., 1996; Ohno et al.,
1996, 1998). Table 2 shows that the consensus sequence of
the first tyrosine-sorting signal of the gp41 tail of clades A to
D most closely matches the preferences of AP-1 and AP-3
complexes. The arginine residue at position Y  3 of the
signal is 100% conserved, and there is almost complete
conservation of the glycine at Y  1 (99.95%), the tyrosine
itself (99.7%), and the proline at Y + 2 (99.8%). The leucine
residue at Y + 3 is 96.9% conserved, but if leucine, isoleucine,
and valine at Y + 3 (all with similar properties and tolerated at
this position of the tyrosine signal) are summed, conservationTable 2
Comparison of the preferences of AP complexes for cellular tyrosine-dependent so
tyrosine-dependent sorting signals of the gp41 of HIV-1 clades A to D
Position
(relative to Y)
AP-1
preferences
AP-2
preferences
A
p
 3 R G R
 2 S F N
 1 L/D P D
0 (Y) Y Y Y
1 (x) Np Np E
2 (x) P P/R P
3 (B) L L I
Np, no preference known at this position; x, any amino acid residue; B, a bulky
a Boll et al. (1996), Heilker et al. (1999), Ho¨ning et al. (1996), Ohno et al. (199
(1997), Stephens and Banting (1998), Stepp et al. (1997).reaches 98.4%. Thus, the first tyrosine-sorting signal
(719YSPL722) could interact with the AP-1 and AP-3
complexes in the TGN and target gp41 to the lysosomes.
However, as stated above, this signal functions at the plasma
membrane (Berlioz-Torrent et al., 1999; Boge et al., 1998;
Deschambeault et al., 1999; Egan et al., 1996; Ohno et al.,
1997; Rowell et al., 1995;West et al., 2002), and is not known
to be active in the TGN. It may be that the amount of gp41
synthesized saturates the lysosomal targeting system in the
TGN, allowing gp41 to reach the cell surface and the first
tyrosine-sorting signal to function as an endocytosis signal.
The possibility that the signal targets gp41 to the lysosomes is
consistent with the observation that the majority of gp160 that
reaches the Golgi is degraded in the lysosomes (Willey et al.,
1988). AP-2 complexes have the broadest specificity range
and associate with the same signals as AP-1 and AP-3
complexes (Ohno et al., 1998). The endocytosis function of
the first tyrosine-sorting signal may enable plasmamembrane
gp41 to be re-directed to the lysosomes if it escapes that route
initially (Ohno et al., 1998).
The second tyrosine-dependent sorting signal
(775YHRL778) has no preceding glycine, and is non-func-
tional in the context of the 1-MSD model of gp41 (Boge et
al., 1998; Rowell et al., 1995). It is situated 63 and 12
residues from the membrane in the 1-MSD and 3-MSD
models, respectively, the latter being close to the optimal 7-
11 residue distance. The residues of the second signal are
variably conserved: 772L = 94.5%, 773F = 96.8%, 774S =
86.0%, 775Y = 99.7%, 776H = 89.3%, 777R = 86.5%, and
778L = 99.8%. The F at position Y  2, R at Y + 2, and L at
Y + 3 suggest that the signal interacts with the AP-2 com-
plex (Table 2). The lack of an R at Y  3, glycine at Y  1,
and proline at Y + 2, and the fact that it is not within the
favored distance from the membrane (Rohrer et al., 1996),
indicate that this signal is not optimal for interacting with
AP-1 or AP-3 complexes. AP-3 complexes disfavor serine
at position Y  1 and makes this interaction less likely
(Ohno et al., 1996, 1998). As yet there is no evidence that
this signal is functional in gp41 (Boge et al., 1998; Rowell
et al., 1995). A peptide containing the signal interactedrting signalsa with the consensus sequence for the first and second potential
P-3
references
HIV-1 tyrosine-dependent sorting signal sequences
First Second
R L
p Q F
/E/G G S
Y Y
S H
P R
L L
hydrophobic residue.
5, 1996, 1998), Ooi et al. (1997), Owen and Evans (1998), Simpson et al.
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Ohno et al., 1997), but the presence of a major upstream
sequence in the 1-MSD model could alter its environment
and its possible interaction with the AP-2 complex.Conclusions
All HIV-1 gp41 tail sequences have a potential N-terminal
GYxxf-sorting signal of the type that would be expected to
interact strongly with AP-1 and AP-3 complexes. Thus, with
the critical 7-residue spacing from the membrane, the signal
is likely to be functionally important in targeting TGN gp41
to lysosomes. If the signal was required only for endocytosis,
it is unlikely that the G at position Y 1, R at Y 3, and the
7-residue spacing from the membrane would be so highly
conserved. However, this would not preclude it from
functioning as an endocytosis signal at the cell surface. The
second Yxxf sequence is not so well conserved, is 63
residues from the membrane in the 1-MSD model, and is
unlikely to interact with AP-1 and AP-3 complexes, or to be
involved in lysosomal targeting from the TGN. However, the
Y is almost completely conserved and the bulky hydrophobic
residue is highly conserved. In the 3-MSD structure of gp41,
only the second signal is on the cytoplasmic side of the
membrane, where it could be functional.
In the infected cell there may be populations of gp41 with
one MSD and three MSDs
Until recently all primate lentivirus envelope protein
anchor components were viewed as having a single MSD
(691–712 in HIV-1; Fig. 4a) (Gallaher, 1987, 1989;
Gonzalez-Scarano et al., 1987; Levy, 1998; White, 1990).
However, published work and the discussion above suggest
that the gp41 tail crosses the membranes of HIV-1 virions
and infected cells three times (Cheung et al., 2005;
Cleveland et al., 2003; McLain et al., 2001). To resolve this
apparent conflict, we shall argue here that the 1- and 3-MSD
forms of gp41 coexist in the infected cell, with the 1-MSD
version being the major form. However, we shall propose
that only the minor 3-MSD form is incorporated into virions.
These proposals are consistent with, and rationalize the
observed degradation of the majority (85–95%) of the1-
MSD form of cellular gp160 (Bultmann et al., 2000;
Courageot et al., 1999; Jabbar and Nayak, 1990; Pfeiffer
et al., 1997; Willey et al., 1988), the apparently contra-
dictory evidence of a functioning first tyrosine-sorting signal
(Berlioz-Torrent et al., 1999; Boge et al., 1998; Descham-
beault et al., 1999; Egan et al., 1996; Ohno et al., 1997;
Rowell et al., 1995; West et al., 2002) and basolateral-sorting
signal (Deschambeault et al., 1999; Lodge et al., 1997;
Owens et al., 1991), with the immunogenic and antigenic
properties of the Kennedy region (Chanh et al., 1986;
Dalgleish et al., 1988; Evans et al., 1989; Ho et al., 1987;
Kennedy et al., 1986; Niedrig et al., 1992).The C-terminal tail of the 1-MSD form of HIV-1 gp41
starts at residue 713 (Fig. 4a). As already stated, the
majority of this type of gp41 (85–95%) is degraded
intracellularly. The Y residue of the first tyrosine-dependent
sorting signal (718GYSPL722) is situated precisely 7 residues
from the membrane and conforms closely to the require-
ments for cellular GYxxf lysosomal targeting signals (see
above). In the 1-MSD form of gp41, the second tyrosine-
dependent sorting signal is apparently not needed, and we
suggest may not be functional.
The 3-MSD form of HIV-1 gp41 has MSDs at 691–700,
703–712, and 754–763, and its 718GYSPL722 sequence is
outside the virion. This model is supported by antigenic and
other data showing that residues of the C-terminal tail are
exposed on the surface of the virion (Buratti et al., 1998;
Chanh et al., 1986; Cleveland et al., 2000a,b,2003;
Dalgleish et al., 1988; Durrani et al., 1998; Ho et al.,
1987; McInerney et al., 1999; McLain et al., 1995, 1996,
2001; Newton et al., 1995; Reading et al., 2003) and the
infected cell (Cheung et al., 2005; Heap et al., 2005).
Furthermore, we propose that this form of gp41 represents
the 5–15% of the TGN gp160 that is directed to the cell
surface. Its GYxxf signal is outside the cell membrane and
cannot function in lysosomal targeting or endocytosis, but
the second potential tyrosine-dependent sorting signal
(775YHRL778), which has none of the requirements for
lysosomal targeting (see above), is 12 residues from the
membrane, and well situated to function in endocytosis and
recycling of cell membrane-inserted gp41. Because of its
location this gp41, in association with gp120, is the major
gp41 form in the cell membrane, and the major gp41form
incorporated into virions. Co-existence of two forms of
gp41 raises questions, which will require further work to
answer. The mechanism by which two forms of gp41 arise is
not known, although translocational pausing may be
involved in formation of the multiple MSDs (Dettenhofer
and Yu, 2001). The 1- and 3-MSD forms are proposed to be
a-helix and h-sheet, respectively, and it is noted above that
structure predications allow for either conformation. Con-
formation may be determined by the length of unbroken
MSD sequence, as a long sequence of lower value a-helix,
can take precedence over a higher value, shorter h-sheet
region (Chou and Fasman, 1978). The conventional 1-MSD
model still has the problem of 703R being centrally located
in the membrane with no counter charge. However, a recent
suggestion that the 703R equivalent in SIV is situated in a
position where it can react with the polar lipid head groups
may provide a solution (West et al., 2001).
Degradation of the 1-MSD gp41 and recycling of the
3-MSD form would both act to reduce the surface expression
of gp120-gp41. This may be important, as high intracellular
concentrations of gp41 can be cytotoxic (Arroyo et al., 1995;
Chernomordik et al., 1994; Comardelle et al., 1997;
Gawrisch et al., 1993; Miller et al., 1993; Zhang et al.,
1996), and provoke immune responses against the infected
cell. It may be that such post-translational control measures,
M.J. Hollier, N.J. Dimmock / Virology 337 (2005) 284–296 293utilizing tyrosine-dependent sorting signals and the host
cell’s degradation pathways, have evolved as envelope
expression is not easily controlled at a genetic level due to
the overlap of the env, tat, and rev ORFs.
The suggestion above that a membrane-inserted viral
protein can have different numbers of MSDs is not unique.
For example, the GL envelope protein of equine arteritis
virus is proposed to have 1 or 3 MSDs (Snijder and
Meulenberg, 1998), the M protein of transmissible gastro-
enteritis coronavirus and equine arteritis virus, and the S
antigen of hepatitis B virus are proposed to have three or
four MSDs (Prange and Streeck, 1995; Risco et al., 1995;
Snijder and Meulenberg, 1998), and the herpes simplex
virus glycoprotein B (Pellett et al., 1985), and the Epstein–
Barr virus 58 kDa latent protein (Fennewald et al., 1984;
Hennessy et al., 1984) both have multiple MSDs.
Summary
Based on an analysis of their sequence and structure, we
propose that the gp41 transmembrane region and C-terminal
tail of all HIV-1 clades A to D can exist in two
conformations, with either 1 MSD (the conventional
structure) or with 3 MSDs. We suggest that these are,
respectively, the majority and minority forms of intracellular
Env. In the 3-MSD form, MSD 1 and MSD 2 are separated
by a highly conserved beta turn, while the MSD 2 and MSD
3 support an unstructured hydrophilic loop/minor ectodo-
main of 41 residues that in clade B strains is highly
antibody-reactive and involved in fusion. All viruses have
two potential tyrosine-dependent sorting signals within the
region analyzed. In the 1-MSD model it is likely that only
the N-terminal signal is functional, and that this interacts
with AP-1 and AP-3 to direct Env from the TGN to
degradation in the lysosomes. In the 3-MSD version, the N-
terminal signal is situated outside the membrane and non-
functional, thus allowing this form of gp41 to reach the cell
membrane. Thus, it seems that the 3-MSD form is the
majority species on the cell surface and hence in virions. We
propose that the second signal is functional in the 3-MSD
gp41, and controls recycling of cell surface Env. The 1- and
3-MSD strategy can be seen as an evolutionary adaptation
that allows HIV-1-infected cells to evade the immune
system or to avoid gp41-induced cytotoxicity.Materials and methods
Sequence analysis
HIV-1 gp41 sequences from infectious viruses, molecular
clones, and PCR products from blood samples from infected
individuals were obtained from http://hiv-web.lanl.gov/. We
analyzed residues 690–793 of HIV-1 (numbering according
to Ratner et al., 1985) of the following number of se-
quences: clade A, n = 25; clade B, n = 245; clade C, n = 61;clade D, n = 26. The sequence analyzed comprises the MSD
and approximately two thirds of the C-terminal tail.
Conserved regions of sequence were aligned, with spaces
as necessary to maintain alignment. The residue occupying
each position was recorded as a percentage, and consensus
sequences constructed for each clade. Sequence conservation
is defined here as poor (<80%), moderate (80–89.9%), high
(90–96.4%), and very high (96.5–100%).
Structure predications
For structure predications we used the consensus se-
quences derived in this report for the gp41 MSD and C-
terminal region of HIV-1 clades A to D. Hydropathy values
assigned to the amino acids are based on water vapor
transfer free energies and the interior–exterior distribution
of amino acid side chains (Kyte and Doolittle, 1982). This
system predicts that a region with a value >1.6 is likely to be
an MSD, and that a region with a value >1.09 is likely to be
sequestered inside the protein. a-Helices and h-sheets were
predicted according to Chou and Fasman (1978), where Pa
is the helix conformational parameter and Ph is the h-sheet
conformational parameter. Any segment of 6 residues with
(Pa) 1.03 and (Pa) > (Ph) is predicted to be ahelical,
and any segment of three residues or longer in a native
protein with (Ph) 1.05 and (Ph) > (Pa) is predicted to be
h-sheet. A segment containing overlapping a- and h-
residues is resolved through conformational boundary
analysis so that (Pa) > (Ph) is a-helical, and (Ph) > (Pa)
is h-sheet. A h-turn occurs where a polypeptide folds back
on itself by nearly 180- and typically requires four
consecutive residues (Chou and Fasman, 1978). However,
a h-turn of two residues occurs between two MSDs of
herpes simplex virus glycoprotein B (Pellett et al., 1985).
The lower cut-off value for h-turns of 0.75 was used here
(Chou and Fasman, 1978). Polarity was determined
according to Zimmerman et al. (1968). Accessibility of a
region of a protein to solvent was predicated using the
percentage buried residues index (Janin, 1979). Low values
indicate a region that is likely to be accessible to solvent and
hence surface exposed, and high values indicate regions not
accessible to the solvent. Predications used a moving
window of 7 residues.Acknowledgments
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